Pediatric high-grade glioma: biologically and clinically in need of new thinking
- PMID: 27282398
- PMCID: PMC5464243
- DOI: 10.1093/neuonc/now101
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Abstract
High-grade gliomas in children are different from those that arise in adults. Recent collaborative molecular analyses of these rare cancers have revealed previously unappreciated connections among chromatin regulation, developmental signaling, and tumorigenesis. As we begin to unravel the unique developmental origins and distinct biological drivers of this heterogeneous group of tumors, clinical trials need to keep pace. It is important to avoid therapeutic strategies developed purely using data obtained from studies on adult glioblastoma. This approach has resulted in repetitive trials and ineffective treatments being applied to these children, with limited improvement in clinical outcome. The authors of this perspective, comprising biology and clinical expertise in the disease, recently convened to discuss the most effective ways to translate the emerging molecular insights into patient benefit. This article reviews our current understanding of pediatric high-grade glioma and suggests approaches for innovative clinical management.
Keywords: DIPG; clinical trials; genomics; glioma; pediatric.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.
Figures
Similar articles
-
Mutations in chromatin machinery and pediatric high-grade glioma.Sci Adv. 2016 Mar 18;2(3):e1501354. doi: 10.1126/sciadv.1501354. eCollection 2016 Mar. Sci Adv. 2016. PMID: 27034984 Free PMC article. Review.
-
Pediatric hemispheric high-grade glioma: targeting the future.Cancer Metastasis Rev. 2020 Mar;39(1):245-260. doi: 10.1007/s10555-020-09850-5. Cancer Metastasis Rev. 2020. PMID: 31989507 Review.
-
The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.Oncotarget. 2017 Jul 18;8(29):47206-47215. doi: 10.18632/oncotarget.17589. Oncotarget. 2017. PMID: 28525381 Free PMC article.
-
The Emerging Molecular Foundations of Pediatric Brain Tumors.J Child Neurol. 2015 Nov;30(13):1838-50. doi: 10.1177/0883073815579709. Epub 2015 Apr 14. J Child Neurol. 2015. PMID: 25873586 Review.
-
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.J Clin Oncol. 2017 Jul 20;35(21):2370-2377. doi: 10.1200/JCO.2017.73.0242. Epub 2017 Jun 22. J Clin Oncol. 2017. PMID: 28640698 Review.
Cited by
-
Updates on management of gliomas in the molecular age.World J Clin Oncol. 2024 Feb 24;15(2):178-194. doi: 10.5306/wjco.v15.i2.178. World J Clin Oncol. 2024. PMID: 38455131 Free PMC article. Review.
-
Expression of lncRNAs in glioma: A lighthouse for patients with glioma.Heliyon. 2024 Jan 24;10(3):e24799. doi: 10.1016/j.heliyon.2024.e24799. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322836 Free PMC article. Review.
-
Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.Clin Transl Med. 2024 Feb;14(2):e1560. doi: 10.1002/ctm2.1560. Clin Transl Med. 2024. PMID: 38299304 Free PMC article. Review.
-
BMP signaling in cancer stemness and differentiation.Cell Regen. 2023 Dec 5;12(1):37. doi: 10.1186/s13619-023-00181-8. Cell Regen. 2023. PMID: 38049682 Free PMC article. Review.
-
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.Cell Biosci. 2023 Nov 13;13(1):207. doi: 10.1186/s13578-023-01166-5. Cell Biosci. 2023. PMID: 37957701 Free PMC article.
References
-
- Northcott PA, Pfister SM, Jones DT. Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies. Lancet Oncol. 2015;16(6):e293–e302. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
